On 14 October 2016, orphan designation (EU/3/16/1763) was granted by the European Commission to Coté Orphan Consulting UK Limited, United Kingdom, for tadekinig alfa for the treatment of haemophagocytic lymphohistiocytosis.
The sponsorship was transferred to Quintiles Ireland Limited, Ireland, in March 2018.
In May 2018 the sponsor, Quintiles Ireland Limited changed name to IQVIA RDS Ireland Limited.
The sponsorship was transferred to YES Pharmaceutical Development Services GmbH in February 2021.
|Disease / condition||
Treatment of haemophagocytic lymphohistiocytosis
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.